Related Experiment Video
Updated: Jun 14, 2026
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Left ventricular pseudoaneurysm and α1-antitrypsin enzyme deficiency: another pathological correlation
Luciano Corda1, Enrico Vizzardi2, Giuseppe De Cicco3
1Internal Medicine, Community Hospital, Brescia, Italy.
International Journal of Cardiology
|April 1, 2010
Summary
Alpha1-antitrypsin deficiency (A1ATD) can affect the heart, leading to left ventricle pseudoaneurysms. This case highlights A1ATD
Area of Science:
- Cardiology
- Genetics
- Vascular Biology
Background:
- Alpha1-antitrypsin deficiency (A1ATD) is primarily associated with lung and liver diseases.
- Emerging evidence links A1ATD to cardiovascular complications, including aortic and coronary artery dissection, and intracranial aneurysms.
- These vascular issues are attributed to impaired vascular wall integrity due to altered elastase levels, modulated by alpha1-antitrypsin (A1AT).
Observation:
- A case report details a patient with A1ATD who developed a large pseudoaneurysm of the left ventricle.
- The patient had no typical predisposing factors for pseudoaneurysm, such as coronary artery disease, myocardial infarction, trauma, or myocarditis.
- This observation suggests a direct impact of A1ATD on myocardial tissue integrity.
Findings:
- Connective tissue impairment in A1ATD can compromise myocardial structure.
- Weakened myocardial wall integrity can lead to sudden rupture and pseudoaneurysm formation.
- Surgical intervention was successfully employed to manage the left ventricular pseudoaneurysm.
Implications:
- A1ATD should be considered in the differential diagnosis of unexplained pseudoaneurysms, particularly in the left ventricle.
- This case expands the known spectrum of cardiovascular manifestations of A1ATD.
- Further research is warranted to elucidate the mechanisms linking A1ATD to myocardial structural abnormalities and to optimize management strategies.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...